The complete low testosterone testing guide: What to order, when to test, and how to read results

A proper low testosterone test starts with symptoms, then confirms deficiency with a fasting morning testosterone blood test and mandatory LH and FSH, using 350 ng/dL for total testosterone and 100 pg/mL for free testosterone as key decision thresholds when symptoms persist. A low number alone is not a diagnosis, and symptoms alone are not enough either. This testosterone testing guide explains how to test for low testosterone accurately, which labs matter, and how the results change treatment.

Key takeaways

• A low testosterone test is diagnostic only when persistent symptoms and biochemical evidence are both present. A laboratory number by itself does not diagnose male hypogonadism.^{[1] [2] [3]}
• The testosterone blood test should be drawn fasting between 07:00 and 11:00, and it should not be done during acute illness because transient functional hypogonadism can falsely lower the result.^{[1] [2]}
• Free testosterone should be measured by equilibrium dialysis with LC-MS/MS. Direct free testosterone immunoassays are not accurate enough for clinical decision making and should be avoided.^{[3] [4]}
• Total testosterone below 350 ng/dL and free testosterone below 100 pg/mL are the main decision thresholds at Veedma when symptoms persist. Benefit from testosterone therapy is greatest in men with more severe deficiency, especially below 230 ng/dL.^{[2] [6]}
• LH and FSH are mandatory. High LH plus low testosterone indicates primary hypogonadism. Low or normal LH plus low testosterone indicates secondary hypogonadism, where Enclomiphene is a strong first line candidate when LH is below 8 mIU/mL.^{[1] [2] [3]}

Start with symptoms and context before ordering labs

Symptoms and signals: Low libido, fewer spontaneous erections, fatigue, and related changes are the clinical signals that make testosterone testing meaningful in the first place.

The relationship: A diagnosis depends on the relationship between persistent symptoms and correctly collected laboratory evidence, not on either piece alone.

Conditions linked to it: Obesity, metabolic syndrome, diabetes, medication effects, and acute illness can all lower testosterone or distort interpretation, which is why context has to be reviewed before labeling a man hypogonadal.

A valid low testosterone test starts with symptoms and clinical context, not a laboratory number.^{[1] [2] [3]}

Hypogonadism means a clinical syndrome in which persistent symptoms coexist with biochemical evidence of testosterone deficiency. According to the AUA guideline and the EAU guideline, the first step is to decide whether the man actually has symptoms and signs suggestive of androgen deficiency before any blood is drawn.^{[1] [2]} If you want the full syndrome definition, see our article on the clinical definition of low testosterone.

This matters because the same testosterone value can mean very different things in different men. A man with low libido, fewer spontaneous erections, fatigue, and a correctly drawn low testosterone blood test may have true hypogonadism. A man with no symptoms and a single borderline number may not. The Endocrine Society guideline also emphasizes that diagnosis requires symptoms plus consistently low serum testosterone, not either finding alone.^[3]

Before ordering a low testosterone test, the provider should also review three practical issues. First, drugs and substances that interfere with testosterone production or interpretation should be identified. Second, concomitant metabolic disease should be documented, especially obesity, metabolic syndrome, and diabetes, because these commonly suppress the axis functionally. Third, possible contraindications to treatment should be recognized early so that testing is interpreted in a safe clinical context rather than in isolation.^{[1] [2]}

That symptoms first approach prevents a common error in men’s health. It stops clinicians from turning a hormone panel into a screening exercise with no clinical question behind it. It also stops the opposite error, which is dismissing a clearly symptomatic man because his total testosterone looks “in range” on a single incomplete lab report.

When and how to do a testosterone blood test

The correct testosterone blood test is a fasting morning sample collected between 07:00 and 11:00 with a reliable assay.^{[1] [2] [3]}

Assay means the laboratory method used to measure a hormone. According to the EAU guideline and the Endocrine Society guideline, testosterone is highest in the morning, which is why timing is not a technical detail. It is part of the diagnosis.^{[2] [3]} A blood draw done at 15:00 may understate a younger man’s true baseline. A nonfasting draw may also shift the result downward. If the goal is to learn how to test for low testosterone accurately, morning fasting sampling is the foundation.

Never test during acute illness. The EAU guideline is explicit that acute or critical illness can produce transient functional hypogonadism, which means a temporary, reversible suppression of the hypothalamic pituitary testicular axis rather than a stable baseline deficiency.^[2] A low value measured during a febrile infection, after surgery, or during hospitalization can therefore misclassify a man as hypogonadal when the issue is short term physiological stress.

According to the AUA guideline, confirmation matters because testosterone varies from day to day.^[1] In practice, a clearly low or borderline result should be repeated on a separate fasting morning draw, especially when symptoms and laboratory data do not line up. Using the same laboratory method for both tests improves comparability.

Practical checklist for the day of testing

• Schedule the draw between 07:00 and 11:00.
• Arrive fasting.
• Do not test during an acute illness or soon after hospitalization.
• Use a reliable assay, ideally LC-MS/MS for sex steroids.^[4]
• Repeat the testosterone blood test on another morning if the result is low, borderline, or inconsistent with symptoms.^{[1] [3]}

What to order in a complete low testosterone test

A complete low testosterone test should include total testosterone, free testosterone, LH, FSH, and a safety panel that explains cause, treatment relevance, and common confounders.^{[1] [2] [3]}

Gonadotropins are the pituitary hormones LH and FSH that signal the testes. Hematocrit is the percentage of blood volume occupied by red blood cells. Both concepts matter because they change interpretation and treatment planning, not just diagnosis.

Core order set

At Veedma, this is the foundation of the men’s health panel used for a thorough low testosterone test. The aim is not to order as many biomarkers as possible. The aim is to order the markers that change diagnosis, treatment choice, and safe follow up.

Conditional add ons

Some tests are not universal, but they become important in the right clinical setting. A lipid panel is useful, especially in overweight men, because dyslipidemia often travels with insulin resistance and functional hypogonadism. A thyroid panel, usually starting with TSH, is appropriate when symptoms could reflect thyroid disease rather than testosterone deficiency. Prolactin deserves special emphasis. Prolactin is a pituitary hormone that can suppress GnRH when elevated. The EAU guideline strongly supports measuring prolactin when secondary hypogonadism is present, meaning low testosterone with low LH, and when low sexual desire is a primary complaint.^[2]

Prolactin testing is how a testosterone testing guide avoids missing treatable pituitary disease. Elevated prolactin can be caused by pituitary adenomas or by medications such as antipsychotics and metoclopramide. Both are treatable causes that should be identified before testosterone therapy is considered.^[2]

One important point at Veedma is what we do not order routinely. We do not order SHBG as a separate test for the purpose of estimating free testosterone, because equilibrium dialysis measures free testosterone directly and avoids the weaknesses of a calculated workaround. If you have been told your labs are “normal” despite symptoms, our article on why a normal testosterone result can still be misleading explains why incomplete testing often misses the real issue.

Why the free testosterone test method matters

The method used for a free testosterone test determines whether the result is clinically usable.^{[3] [4]}

A 2007 Endocrine Society position statement on testosterone measurement made the central point clearly: assay quality is not a minor laboratory issue. It is the difference between a number you can trust and a number that can mislead treatment decisions.^[4] For total testosterone, LC-MS/MS is the most accurate method for sex steroid evaluation. Many routine laboratories still rely on immunoassays, which can be acceptable in some settings for total testosterone, but they are more vulnerable to bias than LC-MS/MS.

Why direct free testosterone immunoassays should be avoided

Direct free testosterone immunoassays are not accurate enough for diagnosis and should be avoided.^{[3] [4]} The Endocrine Society guideline and the earlier position statement both warn that direct free testosterone evaluation by these methods is unreliable. That is why a so called free testosterone result from a standard immunoassay often creates more confusion than clarity.

Why equilibrium dialysis is preferred

Equilibrium dialysis is the gold standard method for direct free testosterone measurement.^[4] It physically separates free hormone from protein bound hormone, which is why it performs better when binding proteins distort the relationship between total testosterone and true bioavailable testosterone. In plain language, it tells you what is actually available to tissues rather than what is merely circulating in total.

This matters most in men whose total testosterone is not obviously low but whose free testosterone may still be deficient. Liver disease and aging can increase SHBG and reduce the biologically active fraction. The practical value of a direct free testosterone test is that it exposes this hidden deficiency without forcing the clinician to rely on a calculated estimate. At Veedma, we use equilibrium dialysis with LC-MS/MS for free testosterone and LC-MS/MS for total testosterone for this reason.

How to read total and free testosterone results

Total testosterone below 350 ng/dL and free testosterone below 100 pg/mL are the main decision thresholds at Veedma when symptoms persist and the sample was collected correctly.^{[2] [3]}

According to the EAU guideline, 350 ng/dL, which is about 12 nmol/L, is a reliable threshold for total testosterone in symptomatic men.^[2] The same guideline also notes that testosterone therapy is generally ineffective when baseline total testosterone is above 350 ng/dL, while the highest benefit is seen in more severe hypogonadism, especially below 230 ng/dL, which is about 8 nmol/L.^{[2] [6]} That is why a low testosterone testing guide should not reduce interpretation to “inside range” versus “outside range.” The threshold only makes sense when symptoms, assay quality, and sampling conditions are right.

Free testosterone requires a more nuanced reading. According to the EAU guideline’s discussion of recent standardized equilibrium dialysis data from healthy nonobese men, age specific distributions look very different from the single adult “normal range” printed on many reports.^[2]

The key clinical insight is the size of the age related drop. The median free testosterone for men over 60, which is 113 pg/mL, sits below the 2.5th percentile for healthy men under 40, which is 120 pg/mL. In other words, an older man can be “average for age” while still being far below the physiology of healthy younger men. That is exactly why direct free testosterone measurement can change the interpretation of a testosterone blood test.

A 2017 JCEM harmonization study also showed why population reference ranges can mislead.^[5] Widely used adult ranges are drawn from mixed populations, not from symptom free healthy young men. That is why a “normal” result can still be clinically unhelpful if the method was poor, the sample was mistimed, or free testosterone was never measured.

How LH and FSH change the diagnosis and treatment path

How it works: LH and FSH show whether the pituitary is sending an adequate signal to the testes, which explains whether the problem begins in the brain or in the testes themselves.

LH and FSH are mandatory because low testosterone cannot be classified as primary or secondary without them.^{[1] [2] [3]}

This is the most consequential part of a low testosterone test. Two men can have the same testosterone value and need different treatment because the problem starts in different places. For a deeper explanation of the framework, see our article on primary vs secondary hypogonadism.

Primary pattern, high LH plus low testosterone

High LH plus low testosterone indicates primary hypogonadism.^{[2] [3]} In plain language, the pituitary is signaling hard, but the testes are not responding. This is testicular failure. Enclomiphene will not fix that physiology because the testes cannot respond adequately to more stimulation. Educationally, this is the pattern in which testosterone replacement is usually required.

Secondary pattern, low or normal LH plus low testosterone

Low or normal LH plus low testosterone indicates secondary hypogonadism.^{[1] [2]} Here, the testes may be intact, but the brain is not sending enough signal. This is the most common real world pattern. It is also the pattern in which Enclomiphene becomes clinically important, because Enclomiphene blocks estrogen feedback at the hypothalamus, increases GnRH and LH, and stimulates the testes to produce testosterone naturally. When LH is below 8 mIU/mL, Enclomiphene is a strong first line option for secondary and functional hypogonadism. Unlike testosterone replacement, it preserves spermatogenesis and testicular function.

What to do about it: Once symptoms, testosterone levels, and LH/FSH pattern line up, the next step is to treat the cause appropriately, using stimulation therapy for secondary patterns when suitable and replacement when primary failure is present.

This is why the LH FSH testosterone test is nonnegotiable. It is the difference between a fertility suppressing lifelong replacement strategy and a fertility preserving stimulation strategy. Any provider who prescribes testosterone without first checking LH and FSH is guessing at treatment.

When prolactin and pituitary evaluation are needed

Prolactin should be measured when low testosterone coexists with low LH or when low sexual desire is the main complaint.^[2] Elevated prolactin suppresses GnRH, which can produce secondary hypogonadism. According to the EAU guideline, a high prolactin result should prompt a search for treatable causes such as medication effects or a pituitary adenoma.^[2]

Headache, visual disturbances, or other signs of anterior pituitary deficiency raise the level of concern further. Those symptoms do not simply add color to the history. They change the workup. In that setting, the low testosterone test is no longer just about confirming deficiency. It is about finding the cause before treatment begins.

Myth vs fact

Myth: A low number alone diagnoses low testosterone

Fact: Male hypogonadism requires persistent symptoms plus biochemical evidence of deficiency. The AUA, EAU, and Endocrine Society all frame diagnosis as a syndrome, not as a lab value in isolation.^{[1] [2] [3]}

Myth: Any time of day is fine for a testosterone blood test

Fact: Morning fasting testing is the standard, and acute illness should delay testing. A poorly timed or nonfasting draw can misstate baseline testosterone, especially in younger men.^{[1] [2]}

Myth: A free testosterone immunoassay is good enough

Fact: Direct free testosterone immunoassays are not recommended for diagnostic use. The preferred free testosterone test is equilibrium dialysis, ideally paired with LC-MS/MS.^{[3] [4]}

Myth: LH and FSH are optional add ons

Fact: LH and FSH determine whether hypogonadism is primary or secondary. Without them, a clinician cannot choose rational treatment and cannot know whether Enclomiphene is appropriate.^{[1] [2]}

Myth: A normal total testosterone rules out deficiency

Fact: Total testosterone can miss men with low free testosterone, particularly when binding proteins distort the biologically active fraction. That is why a complete low testosterone test includes a direct free testosterone test by equilibrium dialysis.^{[2] [4]}

Bottom line

The complete answer to “how to test for low testosterone” is straightforward: start with symptoms, draw fasting morning labs using accurate methods, include free testosterone plus LH and FSH, and interpret the result with 350 ng/dL for total testosterone and 100 pg/mL for free testosterone as key thresholds when symptoms persist. The most important part of reading results is not whether testosterone is low alone. It is whether LH and FSH show primary or secondary hypogonadism, because that determines whether stimulation therapy or replacement therapy makes sense. For the full diagnostic and treatment roadmap, see the Low Testosterone hub.

Veedma offers a thorough diagnostic workup with an advanced lab panel that uses LC-MS/MS for total testosterone and equilibrium dialysis with LC-MS/MS for free testosterone, or a review of existing lab results, including uploads from services such as Function Health. Licensed providers build individualized plans with Enclomiphene as the first line option for secondary and functional hypogonadism, and the Enclomiphene + Tadalafil combination tablet when erection or urinary symptoms are also present, with ongoing monitoring and protocol adjustments over time.

References

1. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. The Journal of urology. 2018;200:423-432. PMID: 29601923
2. Salonia A, Capogrosso P, Boeri L, et al. European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Hypogonadism, Erectile Dysfunction, Premature Ejaculation, and Peyronie’s Disease. European urology. 2025;88:76-102. PMID: 40340108
3. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2018;103:1715-1744. PMID: 29562364
4. Rosner W, Auchus RJ, Azziz R, et al. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. The Journal of clinical endocrinology and metabolism. 2007;92:405-13. PMID: 17090633
5. Travison TG, Vesper HW, Orwoll E, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. The Journal of clinical endocrinology and metabolism. 2017;102:1161-1173. PMID: 28324103
6. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. The New England journal of medicine. 2016;374:611-24. PMID: 26886521